Islet-derived CD4 T cells targeting proinsulin in human autoimmune diabetes

Diabetes

Volumn 66, Issue 3, 2017, Pages 722-734

  Michels, Aaron W ^a   Landry, Laurie G ^a   McDaniel, Kristen A ^a   Yu, Liping ^a   Campbell Thompson, Martha ^b   Kwok, William W ^c,d   Jones, Kenneth L ^e   Gottlieb, Peter A ^a   Kappler, John W ^a,f,g   Tang, Qizhi ^h,i   Roep, Bart O ^j,k   Atkinson, Mark A ^b   Mathews, Clayton E ^b   Nakayama, Maki ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e University of Colorado Denver and Children s Hospital Colorado   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^g DEPARTMENT OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2; PREPROINSULIN; PROINSULIN; T LYMPHOCYTE RECEPTOR; AUTOANTIGEN; C PEPTIDE; INSULIN; INSULIN B (9-23); LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CELL CLONE; CHILD; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGAN DONOR; PANCREAS ISLET; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN TARGETING; YOUNG ADULT; CYTOLOGY; GENETICS; IMMUNOLOGY; PANCREAS ISLET BETA CELL; PATHOLOGY;

ADOLESCENT; AUTOANTIGENS; C-PEPTIDE; CD4-POSITIVE T-LYMPHOCYTES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; PEPTIDE FRAGMENTS; PROINSULIN; PROTEIN PRECURSORS; RECEPTORS, ANTIGEN, T-CELL; YOUNG ADULT;

EID: 85018742541     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-1025     Document Type: Article

References (51)

1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014; 383:69-82
2. Patterson CC, Dahlquist GG, Györös E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet 2009;373:2027-2033
3. Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013;309: 2473-2479
4. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002;346:1685-1691
5. Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1. Diabetes Care 2005;28:1068-1076
6. Näntö-Salonen K, Kupila A, Simell S, et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: A double-blind, randomised controlled trial. Lancet 2008;372: 1746-1755
7. Fourlanos S, Perry C, Gellert SA, et al. Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes. Diabetes 2011; 60:1237-1245
8. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009;360:1646-1654
9. Hu X, Deutsch AJ, Lenz TL, et al. Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat Genet 2015;47:898-905
10. Serreze DV, Leiter EH. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr Opin Immunol 1994;6:900-906
11. Daniel D, Gill RG, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995;25:1056-1062
12. French MB, Allison J, Cram DS, et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 1997;46:34-39
13. Jaeckel E, Lipes MA, von Boehmer H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat Immunol 2004;5:1028-1035
14. Nakayama M, Abiru N, Moriyama H, et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005;435: 220-223
15. Yamamoto T, Yamato E, Tashiro F, et al. Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice. Diabetologia 2004;47:221-224
16. Kubosaki A, Miura J, Notkins AL. IA-2 is not required for the development of diabetes in NOD mice. Diabetologia 2004;47:149-150
17. Krishnamurthy B, Dudek NL, McKenzie MD, et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 2006;116:3258-3265
18. Alleva DG, Crowe PD, Jin L, et al. A disease-Associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 2001;107:173-180
19. Yang J, Chow IT, Sosinowski T, et al. Autoreactive T cells specific for insulin B:11-23 recognize a low-Affinity peptide register in human subjects with autoimmune diabetes. Proc Natl Acad Sci U S A 2014;111:14840-14845
20. Eerligh P, van Lummel M, Zaldumbide A, et al. Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes. Genes Immun 2011;12:415-427
21. Mannering SI, Harrison LC, Williamson NA, et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 2005; 202:1191-1197
22. Knight RR, Kronenberg D, Zhao M, et al. Human b-cell killing by autoreactive preproinsulin-specific CD8 T cells is predominantly granule-mediated with the potency dependent upon T-cell receptor avidity. Diabetes 2013;62:205-213
23. Kent SC, Chen Y, Bregoli L, et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005;435:224-228
24. Pathiraja V, Kuehlich JP, Campbell PD, et al. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-Transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes. Diabetes 2015;64:172-182
25. Pugliese A, Yang M, Kusmarteva I, et al. The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes 2014;15:1-9
26. Yu L, Rewers M, Gianani R, et al. Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996;81:4264-4267
27. Bugawan TL, Erlich HA. Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 1991;33:163-170
28. Bennett ST, Wilson AJ, Esposito L, et al.; The IMDIAB Group. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. Nat Genet 1997;17:350-352
29. Campbell-Thompson M, Wasserfall C, Kaddis J, et al. Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev 2012;28:608-617
30. Campbell-Thompson M, Fu A, Kaddis JS, et al. Insulitis and b-cell mass in the natural history of type 1 diabetes. Diabetes 2016;65:719-731
31. White J, Pullen A, Choi K, Marrack P, Kappler JW. Antigen recognition properties of mutant V beta 3+ T cell receptors are consistent with an immunoglobulin-like structure for the receptor. J Exp Med 1993;177:119-125
32. Wang XX, Li Y, Yin Y, et al. Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex. Proc Natl Acad Sci U S A 2011;108:15960-15965
33. Glimcher LH, McKean DJ, Choi E, Seidman JG. Complex regulation of class II gene expression: Analysis with class II mutant cell lines. J Immunol 1985;135: 3542-3550
34. Pugliese A, Zeller M, Fernandez A Jr, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997;15: 293-297
35. Nakayama M, McDaniel K, Fitzgerald-Miller L, et al. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects. Proc Natl Acad Sci U S A 2015;112:4429-4434
36. Reijonen H, Mallone R, Heninger AK, et al. GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 2004;53:1987-1994
37. Gottlieb PA, Delong T, Baker RL, et al. Chromogranin A is a T cell antigen in human type 1 diabetes. J Autoimmun 2014;50:38-41
38. Tollefsen S, Arentz-Hansen H, Fleckenstein B, et al. HLA-DQ2 and-DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006;116:2226-2236
39. Michels AW, Ostrov DA, Zhang L, et al. Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation. J Immunol 2011;187:5921-5930
40. Corper AL, Stratmann T, Apostolopoulos V, et al. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 2000; 288:505-511
41. Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001;2: 501-507
42. Suri A, Walters JJ, Gross ML, Unanue ER. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. J Clin Invest 2005;115:2268-2276
43. Mohan JF, Levisetti MG, Calderon B, Herzog JW, Petzold SJ, Unanue ER. Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol 2010;11:350-354
44. Crawford F, Stadinski B, Jin N, et al. Specificity and detection of insulinreactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse. Proc Natl Acad Sci U S A 2011;108:16729-16734
45. Erlich H, Valdes AM, Noble J, et al.; Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the type 1 diabetes genetics consortium families. Diabetes 2008;57:1084-1092
46. Delong T, Wiles TA, Baker RL, et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 2016;351:711-714
47. van Lummel M, Duinkerken G, van Veelen PA, et al. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes. Diabetes 2014;63:237-247
48. Lernmark A, Larsson HE. Immune therapy in type 1 diabetes mellitus. Nat Rev Endocrinol 2013;9:92-103
49. Skyler JS. Primary and secondary prevention of type 1 diabetes. Diabet Med 2013;30:161-169
50. Alleva DG, Maki RA, Putnam AL, et al. Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope. Scand J Immunol 2006;63:59-69
51. Bonifacio E, Ziegler AG, Klingensmith G, et al.; Pre-POINT Study Group. Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: The Pre-POINT randomized clinical trial. JAMA 2015;313:1541-1549